Skip to main content
Premium Trial:

Request an Annual Quote

Howard Robin, John Maraganore, Steve Kriegsman, Bob Towarnicki, John Spears, Dale Pfost, and Sam Reich


The Biotechnology Industry Organization’s annual BIO-CEO conference on Feb. 23-24 is featuring an RNAi discussion panel this year featuring six top industry exectives.

Sirna Therapeutics’ president and CEO Howard Robin is set to present, as is Alnylam Pharmaceuticals’ president and CEO John Maraganore.

Additional panel participants include CytRx president and CEO Steven Kriegsman, Nucleonics president and CEO Bob Towarnicki, Intradigm chairman and CEO John Spears, and Acuity Pharmaceuticals president and CEO Dale Pfost.

Representatives for Acuity also noted that the company’s co-founder and senior director of research Sam Reich is scheduled to take part in an ophthalmology discussion panel during the conference.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.